Europe Excluding Germany was the largest of Bruker Corp’s 6 reported lines in fiscal 2025, at $1.90B — 28% of $6.87B.
| Geography | FY 2010 | FY 2014 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Europe Excluding Germany | — | $1.40B | $1.75B | $1.90B | ||||||||
| United States | $1.39B | $1.56B | $1.88B | $1.78B | ||||||||
| Revenues | — | — | — | — | ||||||||
| Rest Of Europe | $1.18B | — | — | — | ||||||||
| Asia Pacific | — | — | — | — | ||||||||
| Asia Pacific Excluding China | — | $921.80M | $1.04B | $1.11B | ||||||||
| China | $793.00M | $1.06B | $942.40M | $951.60M | ||||||||
| Rest Of Asia Pacific | $816.80M | — | — | — | ||||||||
| Germany | $494.80M | $563.00M | $621.40M | $594.00M | ||||||||
| Other | $380.80M | $433.20M | $509.00M | $539.20M | ||||||||
| Total | $5.06B | $5.93B | $6.73B | $6.87B |
In fiscal 2025, which ended December 31, 2025, the 6 regions Bruker Corp reported in this breakdown added up to $6.87B. That was up 2.1% from $6.73B in fiscal 2024. Europe Excluding Germany was the largest region, at $1.90B or 27.7% of the total, followed by United States ($1.78B, 25.9%) and Asia Pacific Excluding China ($1.11B, 16.1%). Together, the two largest regions made up 53.6% of this total.
Compared with fiscal 2024, Europe Excluding Germany grew the fastest, rising 8.8% to $1.90B. United States fell the most, down 5.0% to $1.78B.
Europe Excluding Germany (fiscal 2023) and Asia Pacific Excluding China (fiscal 2023) were first reported as separate regions during this period. The table also keeps 4 regions that Bruker Corp no longer reports, so earlier years can still be read on their original basis; use "Show 4 discontinued" beneath the table to see them. This breakdown covers 12 fiscal years between 2010 and 2025, as reported in Bruker Corp's annual filings.
Bsi Calid was the largest of Bruker Corp’s 4 reported lines in fiscal 2025, at $2.42B — 35% of $6.87B.
| Segment | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Bsi Life Science | — | — | — | — | ||||||
| Bsi | — | — | — | — | ||||||
| Bsi Calid | $1.64B | $1.92B | $2.19B | $2.42B | ||||||
| Bsi Nano | $1.57B | $1.88B | $2.20B | $2.17B | ||||||
| Bsi Biospin | $1.39B | $1.60B | $1.81B | $1.76B | ||||||
| Bruker Biospin | — | — | — | — | ||||||
| Bruker Calid | — | — | — | — | ||||||
| Bsi Material Science | — | — | — | — | ||||||
| Best | $449.60M | $527.40M | $537.80M | $526.40M | ||||||
| Total | $5.06B | $5.93B | $6.73B | $6.87B |
In fiscal 2025, which ended December 31, 2025, the 4 segments Bruker Corp reported in this breakdown added up to $6.87B. That was up 2.1% from $6.73B in fiscal 2024. Bsi Calid was the largest segment, at $2.42B or 35.2% of the total, followed by Bsi Nano ($2.17B, 31.6%) and Bsi Biospin ($1.76B, 25.6%). Together, the two largest segments made up 66.8% of this total.
Compared with fiscal 2024, Bsi Calid grew the fastest, rising 10.7% to $2.42B. Bsi Biospin fell the most, down 3.0% to $1.76B. Over fiscal 2022 to 2025, revenue across these segments went from $5.06B to $6.87B, a compound annual growth rate of 10.7%. Bsi Calid's share of the total rose from 32.5% to 35.2% over the same years.
The table also keeps 5 segments that Bruker Corp no longer reports, so earlier years can still be read on their original basis; use "Show 5 discontinued" beneath the table to see them. This breakdown covers every fiscal year from 2016 to 2025, as reported in Bruker Corp's annual filings.
Product Revenue was the largest of Bruker Corp’s 2 reported lines in fiscal 2025, at $5.53B — 81% of $6.87B.
| Product and Service | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Product Revenue | — | $4.92B | $5.52B | $5.53B | ||||||
| Product | $4.22B | — | — | — | ||||||
| Service | — | — | — | — | ||||||
| Service & Other Revenue | $841.60M | $1.01B | $1.21B | $1.34B | ||||||
| Other | — | — | — | — | ||||||
| Total | $5.06B | $5.93B | $6.73B | $6.87B |
In fiscal 2025, which ended December 31, 2025, the 2 revenue lines Bruker Corp reported in this breakdown added up to $6.87B. That was up 2.1% from $6.73B in fiscal 2024. Product Revenue was the largest revenue line, at $5.53B or 80.5% of the total, followed by Service & Other Revenue ($1.34B, 19.5%).
Compared with fiscal 2024, Service & Other Revenue grew the fastest, rising 10.4% to $1.34B.
Product Revenue was first reported as a separate revenue line in fiscal 2023. The table also keeps 3 revenue lines that Bruker Corp no longer reports, so earlier years can still be read on their original basis; use "Show 3 discontinued" beneath the table to see them. This breakdown covers every fiscal year from 2016 to 2025, as reported in Bruker Corp's annual filings.
Bruker Corp (BRKR) breaks its revenue down by region, segment and revenue line. In fiscal 2025, its largest region was Europe Excluding Germany, with $1.90B or 27.7% of the total, followed by United States at $1.78B (25.9%).
Europe Excluding Germany was Bruker Corp's largest region in fiscal 2025, with $1.90B in revenue, 27.7% of the $6.87B reported across its 6 regions.
Bsi Calid was Bruker Corp's largest segment in fiscal 2025, with $2.42B in revenue, 35.2% of the $6.87B reported across its 4 segments.
Product Revenue was Bruker Corp's largest revenue line in fiscal 2025, with $5.53B in revenue, 80.5% of the $6.87B reported across its 2 revenue lines.
Of the Bruker Corp regions reported in both fiscal 2024 and fiscal 2025, and making up at least 2% of the total, Europe Excluding Germany grew the fastest, rising 8.8% from $1.75B to $1.90B.
Every figure is taken from Bruker Corp's annual financial filings and shown as reported: each line keeps the name the company gives it, years follow its own fiscal calendar, and lines it has stopped reporting stay in the table for the years they were reported.
The breakdown by region covers fiscal 2010 to 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.